Fig. 2From: Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinomaProgression-Free survival (a) and Overall Survival (b) stratified by NLR ≤4 vs >4Back to article page